nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR4—hindbrain—autistic disorder	0.0175	0.0498	CbGeAlD
Ponatinib—FGFR4—brainstem—autistic disorder	0.0101	0.0285	CbGeAlD
Ponatinib—FGFR2—hindbrain—autistic disorder	0.00784	0.0222	CbGeAlD
Ponatinib—FGFR2—mouth—autistic disorder	0.00688	0.0195	CbGeAlD
Ponatinib—FGFR4—digestive system—autistic disorder	0.00681	0.0193	CbGeAlD
Ponatinib—FGFR3—forebrain—autistic disorder	0.00662	0.0188	CbGeAlD
Ponatinib—FGFR3—telencephalon—autistic disorder	0.00609	0.0173	CbGeAlD
Ponatinib—BCR—eye—autistic disorder	0.00578	0.0164	CbGeAlD
Ponatinib—BCR—forebrain—autistic disorder	0.00573	0.0162	CbGeAlD
Ponatinib—FGFR4—head—autistic disorder	0.00556	0.0158	CbGeAlD
Ponatinib—KIT—hindbrain—autistic disorder	0.00544	0.0154	CbGeAlD
Ponatinib—BCR—telencephalon—autistic disorder	0.00527	0.0149	CbGeAlD
Ponatinib—FGFR4—nervous system—autistic disorder	0.00527	0.0149	CbGeAlD
Ponatinib—FGFR4—central nervous system—autistic disorder	0.00507	0.0144	CbGeAlD
Ponatinib—FGFR4—cerebellum—autistic disorder	0.00496	0.0141	CbGeAlD
Ponatinib—KIT—mouth—autistic disorder	0.00477	0.0135	CbGeAlD
Ponatinib—ABL1—hindbrain—autistic disorder	0.00474	0.0134	CbGeAlD
Ponatinib—FGFR1—telencephalon—autistic disorder	0.00469	0.0133	CbGeAlD
Ponatinib—FGFR2—brainstem—autistic disorder	0.00449	0.0127	CbGeAlD
Ponatinib—FGFR2—eye—autistic disorder	0.00437	0.0124	CbGeAlD
Ponatinib—FGFR2—forebrain—autistic disorder	0.00434	0.0123	CbGeAlD
Ponatinib—FGFR4—brain—autistic disorder	0.00403	0.0114	CbGeAlD
Ponatinib—FGFR2—telencephalon—autistic disorder	0.00399	0.0113	CbGeAlD
Ponatinib—TEK—telencephalon—autistic disorder	0.00382	0.0108	CbGeAlD
Ponatinib—LYN—head—autistic disorder	0.00381	0.0108	CbGeAlD
Ponatinib—FGFR3—head—autistic disorder	0.00379	0.0108	CbGeAlD
Ponatinib—PDGFRA—forebrain—autistic disorder	0.00377	0.0107	CbGeAlD
Ponatinib—SRC—eye—autistic disorder	0.00372	0.0106	CbGeAlD
Ponatinib—SRC—forebrain—autistic disorder	0.00369	0.0105	CbGeAlD
Ponatinib—LYN—nervous system—autistic disorder	0.00361	0.0102	CbGeAlD
Ponatinib—FGFR3—nervous system—autistic disorder	0.0036	0.0102	CbGeAlD
Ponatinib—LYN—central nervous system—autistic disorder	0.00348	0.00987	CbGeAlD
Ponatinib—PDGFRA—telencephalon—autistic disorder	0.00346	0.00982	CbGeAlD
Ponatinib—FGFR3—central nervous system—autistic disorder	0.00346	0.00981	CbGeAlD
Ponatinib—KDR—eye—autistic disorder	0.00343	0.00972	CbGeAlD
Ponatinib—KDR—forebrain—autistic disorder	0.0034	0.00963	CbGeAlD
Ponatinib—SRC—telencephalon—autistic disorder	0.0034	0.00963	CbGeAlD
Ponatinib—FGFR3—cerebellum—autistic disorder	0.00338	0.00959	CbGeAlD
Ponatinib—BCR—head—autistic disorder	0.00328	0.0093	CbGeAlD
Ponatinib—RET—digestive system—autistic disorder	0.0032	0.00908	CbGeAlD
Ponatinib—ABCB11—digestive system—autistic disorder	0.00313	0.00887	CbGeAlD
Ponatinib—KIT—brainstem—autistic disorder	0.00312	0.00884	CbGeAlD
Ponatinib—BCR—nervous system—autistic disorder	0.00311	0.00882	CbGeAlD
Ponatinib—FGFR2—digestive system—autistic disorder	0.00304	0.00863	CbGeAlD
Ponatinib—BCR—central nervous system—autistic disorder	0.003	0.00849	CbGeAlD
Ponatinib—BCR—cerebellum—autistic disorder	0.00293	0.0083	CbGeAlD
Ponatinib—FLT3—cerebellum—autistic disorder	0.00291	0.00824	CbGeAlD
Ponatinib—KIT—telencephalon—autistic disorder	0.00277	0.00785	CbGeAlD
Ponatinib—LYN—brain—autistic disorder	0.00276	0.00783	CbGeAlD
Ponatinib—FGFR3—brain—autistic disorder	0.00275	0.00779	CbGeAlD
Ponatinib—ABL1—brainstem—autistic disorder	0.00272	0.0077	CbGeAlD
Ponatinib—ABL1—eye—autistic disorder	0.00264	0.00749	CbGeAlD
Ponatinib—PDGFRA—digestive system—autistic disorder	0.00264	0.00749	CbGeAlD
Ponatinib—RET—head—autistic disorder	0.00261	0.00741	CbGeAlD
Ponatinib—FGFR1—cerebellum—autistic disorder	0.0026	0.00739	CbGeAlD
Ponatinib—SRC—digestive system—autistic disorder	0.00259	0.00735	CbGeAlD
Ponatinib—FGFR2—head—autistic disorder	0.00248	0.00704	CbGeAlD
Ponatinib—RET—nervous system—autistic disorder	0.00248	0.00702	CbGeAlD
Ponatinib—ABL1—telencephalon—autistic disorder	0.00241	0.00683	CbGeAlD
Ponatinib—RET—central nervous system—autistic disorder	0.00238	0.00676	CbGeAlD
Ponatinib—KDR—digestive system—autistic disorder	0.00238	0.00676	CbGeAlD
Ponatinib—TEK—head—autistic disorder	0.00238	0.00675	CbGeAlD
Ponatinib—BCR—brain—autistic disorder	0.00238	0.00674	CbGeAlD
Ponatinib—FGFR2—nervous system—autistic disorder	0.00235	0.00667	CbGeAlD
Ponatinib—RET—cerebellum—autistic disorder	0.00233	0.00661	CbGeAlD
Ponatinib—FGFR2—central nervous system—autistic disorder	0.00227	0.00642	CbGeAlD
Ponatinib—TEK—nervous system—autistic disorder	0.00226	0.0064	CbGeAlD
Ponatinib—FGFR2—cerebellum—autistic disorder	0.00221	0.00628	CbGeAlD
Ponatinib—TEK—central nervous system—autistic disorder	0.00217	0.00616	CbGeAlD
Ponatinib—PDGFRA—head—autistic disorder	0.00216	0.00611	CbGeAlD
Ponatinib—TEK—cerebellum—autistic disorder	0.00212	0.00602	CbGeAlD
Ponatinib—FGFR1—brain—autistic disorder	0.00212	0.006	CbGeAlD
Ponatinib—SRC—head—autistic disorder	0.00211	0.006	CbGeAlD
Ponatinib—KIT—digestive system—autistic disorder	0.00211	0.00599	CbGeAlD
Ponatinib—CYP2D6—hindbrain—autistic disorder	0.00205	0.00581	CbGeAlD
Ponatinib—PDGFRA—nervous system—autistic disorder	0.00204	0.0058	CbGeAlD
Ponatinib—SRC—nervous system—autistic disorder	0.002	0.00568	CbGeAlD
Ponatinib—PDGFRA—central nervous system—autistic disorder	0.00197	0.00558	CbGeAlD
Ponatinib—KDR—head—autistic disorder	0.00195	0.00551	CbGeAlD
Ponatinib—SRC—central nervous system—autistic disorder	0.00193	0.00547	CbGeAlD
Ponatinib—PDGFRA—cerebellum—autistic disorder	0.00192	0.00545	CbGeAlD
Ponatinib—RET—brain—autistic disorder	0.00189	0.00537	CbGeAlD
Ponatinib—SRC—cerebellum—autistic disorder	0.00189	0.00535	CbGeAlD
Ponatinib—KDR—nervous system—autistic disorder	0.00184	0.00523	CbGeAlD
Ponatinib—ABL1—digestive system—autistic disorder	0.00184	0.00522	CbGeAlD
Ponatinib—FGFR2—brain—autistic disorder	0.0018	0.0051	CbGeAlD
Ponatinib—KDR—central nervous system—autistic disorder	0.00178	0.00503	CbGeAlD
Ponatinib—KDR—cerebellum—autistic disorder	0.00174	0.00492	CbGeAlD
Ponatinib—TEK—brain—autistic disorder	0.00172	0.00489	CbGeAlD
Ponatinib—KIT—head—autistic disorder	0.00172	0.00489	CbGeAlD
Ponatinib—KIT—nervous system—autistic disorder	0.00163	0.00463	CbGeAlD
Ponatinib—KIT—central nervous system—autistic disorder	0.00157	0.00446	CbGeAlD
Ponatinib—PDGFRA—brain—autistic disorder	0.00156	0.00443	CbGeAlD
Ponatinib—KIT—cerebellum—autistic disorder	0.00154	0.00436	CbGeAlD
Ponatinib—SRC—brain—autistic disorder	0.00153	0.00434	CbGeAlD
Ponatinib—ABCG2—telencephalon—autistic disorder	0.00152	0.00431	CbGeAlD
Ponatinib—ABL1—head—autistic disorder	0.0015	0.00425	CbGeAlD
Ponatinib—ABL1—nervous system—autistic disorder	0.00142	0.00403	CbGeAlD
Ponatinib—KDR—brain—autistic disorder	0.00141	0.004	CbGeAlD
Ponatinib—ABL1—central nervous system—autistic disorder	0.00137	0.00388	CbGeAlD
Ponatinib—ABL1—cerebellum—autistic disorder	0.00134	0.0038	CbGeAlD
Ponatinib—KIT—brain—autistic disorder	0.00125	0.00354	CbGeAlD
Ponatinib—CYP2D6—brainstem—autistic disorder	0.00117	0.00333	CbGeAlD
Ponatinib—CYP2D6—forebrain—autistic disorder	0.00113	0.00321	CbGeAlD
Ponatinib—ABL1—brain—autistic disorder	0.00109	0.00308	CbGeAlD
Ponatinib—CYP3A5—digestive system—autistic disorder	0.00108	0.00305	CbGeAlD
Ponatinib—CYP2D6—telencephalon—autistic disorder	0.00104	0.00295	CbGeAlD
Ponatinib—ABCG2—cerebellum—autistic disorder	0.000844	0.00239	CbGeAlD
Ponatinib—ABCB1—forebrain—autistic disorder	0.000815	0.00231	CbGeAlD
Ponatinib—CYP3A4—digestive system—autistic disorder	0.000808	0.00229	CbGeAlD
Ponatinib—CYP2D6—digestive system—autistic disorder	0.000795	0.00225	CbGeAlD
Ponatinib—ABCB1—telencephalon—autistic disorder	0.000749	0.00212	CbGeAlD
Ponatinib—CYP2C8—brain—autistic disorder	0.000705	0.002	CbGeAlD
Ponatinib—ABCG2—brain—autistic disorder	0.000686	0.00194	CbGeAlD
Ponatinib—CYP2D6—head—autistic disorder	0.000649	0.00184	CbGeAlD
Ponatinib—CYP3A4—nervous system—autistic disorder	0.000625	0.00177	CbGeAlD
Ponatinib—CYP2D6—nervous system—autistic disorder	0.000615	0.00174	CbGeAlD
Ponatinib—CYP3A4—central nervous system—autistic disorder	0.000602	0.00171	CbGeAlD
Ponatinib—CYP2D6—central nervous system—autistic disorder	0.000592	0.00168	CbGeAlD
Ponatinib—CYP2D6—cerebellum—autistic disorder	0.000579	0.00164	CbGeAlD
Ponatinib—ABCB1—digestive system—autistic disorder	0.000572	0.00162	CbGeAlD
Ponatinib—CYP2D6—brain—autistic disorder	0.00047	0.00133	CbGeAlD
Ponatinib—ABCB1—head—autistic disorder	0.000467	0.00132	CbGeAlD
Ponatinib—ABCB1—nervous system—autistic disorder	0.000442	0.00125	CbGeAlD
Ponatinib—ABCB1—central nervous system—autistic disorder	0.000426	0.00121	CbGeAlD
Ponatinib—ABCB1—cerebellum—autistic disorder	0.000416	0.00118	CbGeAlD
Ponatinib—ABCB1—brain—autistic disorder	0.000338	0.000959	CbGeAlD
Ponatinib—LCK—Signaling Pathways—MEF2C—autistic disorder	1.38e-05	2.13e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—PTEN—autistic disorder	1.37e-05	2.12e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—XDH—autistic disorder	1.37e-05	2.12e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS2—autistic disorder	1.37e-05	2.12e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SERPINE1—autistic disorder	1.36e-05	2.1e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—APOE—autistic disorder	1.35e-05	2.08e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NPAS2—autistic disorder	1.35e-05	2.08e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—STX1A—autistic disorder	1.35e-05	2.08e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—IL6—autistic disorder	1.34e-05	2.07e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ITGB3—autistic disorder	1.34e-05	2.07e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PRKCB—autistic disorder	1.34e-05	2.07e-05	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—HRAS—autistic disorder	1.34e-05	2.07e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SERPINE1—autistic disorder	1.33e-05	2.06e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IGF1—autistic disorder	1.33e-05	2.06e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AVP—autistic disorder	1.33e-05	2.06e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—DHFR—autistic disorder	1.33e-05	2.06e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IGF1—autistic disorder	1.33e-05	2.06e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—MAPK1—autistic disorder	1.33e-05	2.05e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—APC—autistic disorder	1.33e-05	2.05e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—HRAS—autistic disorder	1.33e-05	2.05e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IGF2—autistic disorder	1.33e-05	2.05e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—EGF—autistic disorder	1.31e-05	2.03e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—PTEN—autistic disorder	1.31e-05	2.03e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—PTEN—autistic disorder	1.31e-05	2.03e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—PTEN—autistic disorder	1.31e-05	2.02e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—SERPINE1—autistic disorder	1.3e-05	2.02e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—MAPK1—autistic disorder	1.3e-05	2.01e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—TCN2—autistic disorder	1.3e-05	2.01e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—BCL2—autistic disorder	1.3e-05	2.01e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.29e-05	1.99e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFNG—autistic disorder	1.29e-05	1.99e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—COMT—autistic disorder	1.28e-05	1.98e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—APC—autistic disorder	1.28e-05	1.98e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PIK3CG—autistic disorder	1.28e-05	1.98e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—MAPK1—autistic disorder	1.28e-05	1.97e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GSTP1—autistic disorder	1.28e-05	1.97e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—MAOA—autistic disorder	1.28e-05	1.97e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—autistic disorder	1.27e-05	1.96e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—EGF—autistic disorder	1.27e-05	1.96e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SERPINE1—autistic disorder	1.27e-05	1.96e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SERPINE1—autistic disorder	1.26e-05	1.95e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—DHFR—autistic disorder	1.25e-05	1.94e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PLA2G4A—autistic disorder	1.25e-05	1.94e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HTR2A—autistic disorder	1.25e-05	1.93e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CAT—autistic disorder	1.24e-05	1.92e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADA—autistic disorder	1.24e-05	1.92e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MAPK1—autistic disorder	1.22e-05	1.89e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—POMC—autistic disorder	1.22e-05	1.88e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTEN—autistic disorder	1.22e-05	1.88e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MEF2C—autistic disorder	1.22e-05	1.88e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PIK3CG—autistic disorder	1.22e-05	1.88e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—MAPK1—autistic disorder	1.21e-05	1.87e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—MAPK1—autistic disorder	1.21e-05	1.87e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—HRAS—autistic disorder	1.21e-05	1.87e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—HRAS—autistic disorder	1.21e-05	1.86e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—MAPK1—autistic disorder	1.2e-05	1.86e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CYP19A1—autistic disorder	1.2e-05	1.85e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TSC2—autistic disorder	1.19e-05	1.84e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ITGB3—autistic disorder	1.19e-05	1.83e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—HRAS—autistic disorder	1.19e-05	1.83e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—MAPK1—autistic disorder	1.18e-05	1.82e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PLA2G4A—autistic disorder	1.17e-05	1.81e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GSTM1—autistic disorder	1.17e-05	1.81e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IGF1—autistic disorder	1.17e-05	1.81e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—APOE—autistic disorder	1.16e-05	1.8e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LEP—autistic disorder	1.16e-05	1.8e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—POMC—autistic disorder	1.16e-05	1.79e-05	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HRAS—autistic disorder	1.16e-05	1.79e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—autistic disorder	1.16e-05	1.79e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—SERPINE1—autistic disorder	1.15e-05	1.78e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—autistic disorder	1.15e-05	1.78e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—BCL2—autistic disorder	1.15e-05	1.78e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL2—autistic disorder	1.14e-05	1.77e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—autistic disorder	1.14e-05	1.76e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—autistic disorder	1.14e-05	1.76e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—RORA—autistic disorder	1.13e-05	1.75e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GPX1—autistic disorder	1.12e-05	1.74e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.12e-05	1.73e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—MAPK1—autistic disorder	1.12e-05	1.73e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—MAPK1—autistic disorder	1.12e-05	1.73e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SERPINE1—autistic disorder	1.11e-05	1.72e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—COMT—autistic disorder	1.11e-05	1.72e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HTR2A—autistic disorder	1.11e-05	1.71e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GSTP1—autistic disorder	1.11e-05	1.71e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MAOA—autistic disorder	1.1e-05	1.71e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL2—autistic disorder	1.1e-05	1.7e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PRKCB—autistic disorder	1.1e-05	1.7e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL2—autistic disorder	1.08e-05	1.67e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CAT—autistic disorder	1.08e-05	1.66e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—PTEN—autistic disorder	1.08e-05	1.66e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—HRAS—autistic disorder	1.07e-05	1.65e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—MAPK1—autistic disorder	1.07e-05	1.65e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MAPK1—autistic disorder	1.07e-05	1.65e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—MAPK1—autistic disorder	1.06e-05	1.64e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MAOB—autistic disorder	1.06e-05	1.64e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TSC2—autistic disorder	1.05e-05	1.63e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—APC—autistic disorder	1.05e-05	1.62e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PIK3CG—autistic disorder	1.05e-05	1.62e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HRAS—autistic disorder	1.04e-05	1.61e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP19A1—autistic disorder	1.04e-05	1.61e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—EGF—autistic disorder	1.04e-05	1.6e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—MTHFR—autistic disorder	1.04e-05	1.6e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PTEN—autistic disorder	1.03e-05	1.6e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LEP—autistic disorder	1.03e-05	1.59e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—APOE—autistic disorder	1.03e-05	1.59e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—HRAS—autistic disorder	1.03e-05	1.59e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL2—autistic disorder	1.03e-05	1.58e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HRAS—autistic disorder	1.02e-05	1.58e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL2—autistic disorder	1.02e-05	1.58e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—autistic disorder	1.02e-05	1.58e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GSTM1—autistic disorder	1.02e-05	1.57e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PLA2G4A—autistic disorder	1.02e-05	1.57e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PTEN—autistic disorder	1.02e-05	1.57e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL2—autistic disorder	1.01e-05	1.56e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—autistic disorder	1.01e-05	1.56e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—POMC—autistic disorder	1e-05	1.54e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—autistic disorder	1e-05	1.54e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTEN—autistic disorder	9.93e-06	1.53e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—TPH2—autistic disorder	9.85e-06	1.52e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP19A1—autistic disorder	9.82e-06	1.52e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HRAS—autistic disorder	9.82e-06	1.52e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—autistic disorder	9.82e-06	1.52e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GPX1—autistic disorder	9.74e-06	1.5e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HRAS—autistic disorder	9.74e-06	1.5e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PRKCB—autistic disorder	9.72e-06	1.5e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HRAS—autistic disorder	9.71e-06	1.5e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DPYD—autistic disorder	9.69e-06	1.5e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—COMT—autistic disorder	9.69e-06	1.5e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—APOE—autistic disorder	9.66e-06	1.49e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PTEN—autistic disorder	9.65e-06	1.49e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—HRAS—autistic disorder	9.65e-06	1.49e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GSTP1—autistic disorder	9.64e-06	1.49e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PTEN—autistic disorder	9.62e-06	1.49e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MAOA—autistic disorder	9.62e-06	1.49e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IGF1—autistic disorder	9.62e-06	1.49e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—PTEN—autistic disorder	9.53e-06	1.47e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—HRAS—autistic disorder	9.47e-06	1.46e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—autistic disorder	9.4e-06	1.45e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CAT—autistic disorder	9.38e-06	1.45e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—autistic disorder	9.32e-06	1.44e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PIK3CG—autistic disorder	9.3e-06	1.44e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—APC—autistic disorder	9.3e-06	1.44e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—autistic disorder	9.3e-06	1.44e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—autistic disorder	9.24e-06	1.43e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—autistic disorder	9.23e-06	1.43e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EGF—autistic disorder	9.19e-06	1.42e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SERPINE1—autistic disorder	9.13e-06	1.41e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—COMT—autistic disorder	9.13e-06	1.41e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GSTP1—autistic disorder	9.09e-06	1.4e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—autistic disorder	9.07e-06	1.4e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MAOA—autistic disorder	9.07e-06	1.4e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2—autistic disorder	9.02e-06	1.39e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	9.01e-06	1.39e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—HRAS—autistic disorder	8.99e-06	1.39e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MTHFR—autistic disorder	8.99e-06	1.39e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—HRAS—autistic disorder	8.97e-06	1.39e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PLA2G4A—autistic disorder	8.86e-06	1.37e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GSTM1—autistic disorder	8.86e-06	1.37e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—POMC—autistic disorder	8.85e-06	1.37e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CAT—autistic disorder	8.84e-06	1.37e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTEN—autistic disorder	8.79e-06	1.36e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—MAPK1—autistic disorder	8.75e-06	1.35e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PIK3CG—autistic disorder	8.72e-06	1.35e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—autistic disorder	8.61e-06	1.33e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—autistic disorder	8.58e-06	1.33e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—HRAS—autistic disorder	8.57e-06	1.32e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HRAS—autistic disorder	8.56e-06	1.32e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HRAS—autistic disorder	8.53e-06	1.32e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IGF1—autistic disorder	8.52e-06	1.32e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GPX1—autistic disorder	8.49e-06	1.31e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PTEN—autistic disorder	8.49e-06	1.31e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MAPK1—autistic disorder	8.41e-06	1.3e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—APOE—autistic disorder	8.37e-06	1.29e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GSTM1—autistic disorder	8.35e-06	1.29e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PLA2G4A—autistic disorder	8.35e-06	1.29e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—POMC—autistic disorder	8.3e-06	1.28e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MAPK1—autistic disorder	8.26e-06	1.28e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—autistic disorder	8.2e-06	1.27e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DHFR—autistic disorder	8.2e-06	1.27e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—autistic disorder	8.19e-06	1.27e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—autistic disorder	8.16e-06	1.26e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SERPINE1—autistic disorder	8.09e-06	1.25e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—MAPK1—autistic disorder	8.08e-06	1.25e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTEN—autistic disorder	8.06e-06	1.25e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GPX1—autistic disorder	8e-06	1.24e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MAPK1—autistic disorder	7.84e-06	1.21e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MTHFR—autistic disorder	7.83e-06	1.21e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MAPK1—autistic disorder	7.82e-06	1.21e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—MAPK1—autistic disorder	7.74e-06	1.2e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PIK3CG—autistic disorder	7.55e-06	1.17e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2—autistic disorder	7.39e-06	1.14e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MTHFR—autistic disorder	7.38e-06	1.14e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOE—autistic disorder	7.29e-06	1.13e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—POMC—autistic disorder	7.19e-06	1.11e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—MAPK1—autistic disorder	7.15e-06	1.1e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—HRAS—autistic disorder	7.02e-06	1.08e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PTEN—autistic disorder	6.96e-06	1.07e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MAPK1—autistic disorder	6.9e-06	1.07e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOE—autistic disorder	6.87e-06	1.06e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HRAS—autistic disorder	6.76e-06	1.04e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—autistic disorder	6.72e-06	1.04e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HRAS—autistic disorder	6.63e-06	1.02e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—autistic disorder	6.62e-06	1.02e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PIK3CG—autistic disorder	6.58e-06	1.02e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2—autistic disorder	6.55e-06	1.01e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—HRAS—autistic disorder	6.48e-06	1e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—autistic disorder	6.47e-06	9.99e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	6.42e-06	9.92e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—autistic disorder	6.35e-06	9.81e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HRAS—autistic disorder	6.3e-06	9.73e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HRAS—autistic disorder	6.28e-06	9.7e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—POMC—autistic disorder	6.26e-06	9.68e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—HRAS—autistic disorder	6.22e-06	9.6e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—autistic disorder	6.21e-06	9.59e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PIK3CG—autistic disorder	6.2e-06	9.58e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PTEN—autistic disorder	6.16e-06	9.51e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—autistic disorder	6.03e-06	9.31e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—autistic disorder	6.01e-06	9.29e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—COMT—autistic disorder	5.97e-06	9.22e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—autistic disorder	5.95e-06	9.19e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GSTP1—autistic disorder	5.94e-06	9.18e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MAOA—autistic disorder	5.93e-06	9.16e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—POMC—autistic disorder	5.9e-06	9.12e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CAT—autistic disorder	5.78e-06	8.93e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTEN—autistic disorder	5.77e-06	8.92e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—HRAS—autistic disorder	5.74e-06	8.87e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—autistic disorder	5.74e-06	8.86e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MAPK1—autistic disorder	5.66e-06	8.74e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HRAS—autistic disorder	5.54e-06	8.56e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—autistic disorder	5.49e-06	8.49e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	5.46e-06	8.44e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GSTM1—autistic disorder	5.46e-06	8.44e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—autistic disorder	5.3e-06	8.19e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GPX1—autistic disorder	5.23e-06	8.08e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MAPK1—autistic disorder	5.01e-06	7.73e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTEN—autistic disorder	5e-06	7.73e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—autistic disorder	5e-06	7.72e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MTHFR—autistic disorder	4.83e-06	7.45e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—autistic disorder	4.71e-06	7.27e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HRAS—autistic disorder	4.54e-06	7.01e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOE—autistic disorder	4.49e-06	6.94e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTEN—autistic disorder	4.36e-06	6.73e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—autistic disorder	4.35e-06	6.71e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTEN—autistic disorder	4.11e-06	6.34e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	4.05e-06	6.26e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HRAS—autistic disorder	4.02e-06	6.21e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—POMC—autistic disorder	3.86e-06	5.96e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—autistic disorder	3.85e-06	5.94e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—autistic disorder	3.08e-06	4.76e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTEN—autistic disorder	2.68e-06	4.15e-06	CbGpPWpGaD
